As Acute respiratory failure (ARF) is a challenging serious condition especially when it necessitates intubation to deliver mechanical ventilation which is a fundamental strategy for supporting the respiratory function when the patient can't bear all work of breathing. Even if it represents a life-saving procedure, mechanical ventilation (MV) is associated to life-threatening complications as respiratory muscle dysfunction, and atrophy that lead to long stay in intensive care unit (ICU) and higher mortality. Weaning difficulty is experienced in nearly 30 percent of critically ill patients. The decision to extubate mechanically ventilated patients should be aimed at preventing both the risk of premature liberation from MV which is associated with poor outcome and the risk of delayed extubation which increases the complications of prolonged MV and there is increasing evidence that MV itself may adversely affect the diaphragm's structure and function, which has been termed ventilator-induced diaphragmatic dysfunction (VIDD). The combination of positive pressure ventilation and positive end-expiratory pressure may unload the diaphragm which leads to changes in myofibril length and rapid atrophy that occurs within hours of MV, caused by an imbalance between protein synthesis and proteolysis, lead to a large reduction in the inspiratory pressure generated by the diaphragm.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Blood gases analysis
Timeframe: Blood gases will be analyzed and recorded for all patients pre and post the treatment program duration 5 up to 7 days
Oxygenation Index (OI)
Timeframe: OI will be recorded for three study groups pre and post the treatment program duration 5 up to 7 days
Maximum Inspiratory Pressure (MIP)
Timeframe: MIP will be measured digitally from the MV for all patients pre and post the treatment program duration 5 up to 7 days.
Rapid shallow breathing index (RSBI)
Timeframe: RSBI was measured for all patients pre and post the treatment program duration 5 up to 7 days
Weaning Success Rate
Timeframe: it will be recorded for three study groups post the treatment program duration 5 up to 7 days